These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 34000249

  • 1. Brief history of the medical and non-medical use of amphetamine-like psychostimulants.
    Morelli M, Tognotti E.
    Exp Neurol; 2021 Aug; 342():113754. PubMed ID: 34000249
    [Abstract] [Full Text] [Related]

  • 2. The early history of the neuroscience of attention-deficit/hyperactivity disorder.
    Baumeister AA, Henderson K, Pow JL, Advokat C.
    J Hist Neurosci; 2012 Jul; 21(3):263-79. PubMed ID: 22724488
    [Abstract] [Full Text] [Related]

  • 3. Potential adverse effects of amphetamine treatment on brain and behavior: a review.
    Berman SM, Kuczenski R, McCracken JT, London ED.
    Mol Psychiatry; 2009 Feb; 14(2):123-42. PubMed ID: 18698321
    [Abstract] [Full Text] [Related]

  • 4. Attention-Deficit/Hyperactivity Disorder: A Historical Review (1775 to Present).
    Leahy LG.
    J Psychosoc Nurs Ment Health Serv; 2017 Sep 01; 55(9):10-16. PubMed ID: 28850646
    [Abstract] [Full Text] [Related]

  • 5. Origin of stimulant use for treatment of attention deficit disorder.
    Gross MD.
    Am J Psychiatry; 1995 Feb 01; 152(2):298-9. PubMed ID: 7840374
    [No Abstract] [Full Text] [Related]

  • 6. Attention deficit hyperactivity disorder.
    Barnett R.
    Lancet; 2016 Feb 20; 387(10020):737. PubMed ID: 26913307
    [No Abstract] [Full Text] [Related]

  • 7. Suffer the restless children: the evolution of ADHD and paediatric stimulant use, 1900-80.
    Mayes R, Rafalovich A.
    Hist Psychiatry; 2007 Dec 20; 18(72 Pt 4):435-57. PubMed ID: 18590022
    [Abstract] [Full Text] [Related]

  • 8. Brain gain: the underground world of neuroenhancing drugs.
    Talbot M.
    New Yorker; 2009 Apr 27; ():32-43. PubMed ID: 19399986
    [No Abstract] [Full Text] [Related]

  • 9. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
    Quintana H, Cherlin EA, Duesenberg DA, Bangs ME, Ramsey JL, Feldman PD, Allen AJ, Kelsey DK.
    Clin Ther; 2007 Jun 27; 29(6):1168-77. PubMed ID: 17692731
    [Abstract] [Full Text] [Related]

  • 10. Methamphetamine for Hitler's Germany: 1937 to 1945.
    Defalque RJ, Wright AJ.
    Bull Anesth Hist; 2011 Apr 27; 29(2):21-4, 32. PubMed ID: 22849208
    [Abstract] [Full Text] [Related]

  • 11. Commentary with a historical perspective by a child psychiatrist: when "ADHD" was the "brain-damaged child".
    Eisenberg L.
    J Child Adolesc Psychopharmacol; 2007 Jun 27; 17(3):279-83. PubMed ID: 17630858
    [No Abstract] [Full Text] [Related]

  • 12. Risk of Irritability With Psychostimulant Treatment in Children With ADHD: A Meta-Analysis.
    Stuckelman ZD, Mulqueen JM, Ferracioli-Oda E, Cohen SC, Coughlin CG, Leckman JF, Bloch MH.
    J Clin Psychiatry; 2017 Jun 27; 78(6):e648-e655. PubMed ID: 28682529
    [Abstract] [Full Text] [Related]

  • 13. DARK Classics in Chemical Neuroscience: Methamphetamine.
    Abbruscato TJ, Trippier PC.
    ACS Chem Neurosci; 2018 Oct 17; 9(10):2373-2378. PubMed ID: 29602278
    [Abstract] [Full Text] [Related]

  • 14. ADHD drugs: values that drive the debates and decisions.
    Hawthorne S.
    Med Health Care Philos; 2007 Jun 17; 10(2):129-40. PubMed ID: 17486432
    [Abstract] [Full Text] [Related]

  • 15. Attention-deficit hyperactivity disorder: a UK perspective.
    Hill P.
    Nat Clin Pract Neurol; 2008 Mar 17; 4(3):120-1. PubMed ID: 18227823
    [No Abstract] [Full Text] [Related]

  • 16. Psychostimulant treatment for ADHD is modulated by prefrontal cortex manipulation.
    Tang A, Wanchoo SJ, Swann AC, Dafny N.
    Brain Res Bull; 2009 Dec 16; 80(6):353-8. PubMed ID: 19729055
    [Abstract] [Full Text] [Related]

  • 17. ["The amphetamine treatment helped my child". Is it time to reevaluate Swedish practice in hyperactivity syndrome?].
    Lakartidningen; 1996 Nov 20; 93(47):4307-8. PubMed ID: 8984302
    [No Abstract] [Full Text] [Related]

  • 18. Attention-deficit/hyperactivity disorder-specific quality of life with triple-bead mixed amphetamine salts (SPD465) in adults: results of a randomized, double-blind, placebo-controlled study.
    Spencer TJ, Landgraf JM, Adler LA, Weisler RH, Anderson CS, Youcha SH.
    J Clin Psychiatry; 2008 Nov 20; 69(11):1766-75. PubMed ID: 19026251
    [Abstract] [Full Text] [Related]

  • 19. Stimulant therapy in the management of ADHD: mixed amphetamine salts (extended release).
    Faraone SV.
    Expert Opin Pharmacother; 2007 Sep 20; 8(13):2127-34. PubMed ID: 17714065
    [Abstract] [Full Text] [Related]

  • 20. The use of stimulant medications for non-core aspects of ADHD and in other disorders.
    Sinita E, Coghill D.
    Neuropharmacology; 2014 Dec 20; 87():161-72. PubMed ID: 24951855
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.